WuXi PharmaTech Shs Sponsored American Deposit Receipt Repr 8 Shs $35.26

up +0.06


16/9/2014 04:02 PM  |  NYSE : WX  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get WX Trend Analysis - it has outperformed the S&P 500 by 18%

Partner Headlines

  1. Wuxi Pharmatech

    IBD
  2. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  3. WUXI PHARMATECH

    IBD
  4. Cisco, Vipshop Up After-Hours On Earnings Surprises

    IBD
  5. Dow, S&P Hit Records, But End Little Changed

    IBD
  6. 3 Leading Chinese Stocks Among Top Mutual Fund Buys

    IBD
  7. 5 Leading Chinese Stocks To Keep An Eye On

    IBD
  8. IBD 50: Auto, Other IBD 50 Stocks Forming Bases

    IBD
  9. Stocks Back Out Of Early Gains; SanDisk, Chipotle Rise

    IBD
  10. GasLog, Spirit Airlines Top 5 Young Guns Stocks List

    IBD
  11. 5 Highly Rated Stocks Mutual Funds Are Buying

    IBD
  12. Meet 5 Highly Rated Stocks Mutual Funds Are Buying

    IBD
  13. Four Top World Stocks Offer Follow-On Buy Points

    IBD
  14. Myriad Gaps Up To High On Reimbursement Rate Change

    IBD
  15. WuXi PharmaTech Corporate Venture Fund Invests in TruTag Security Platform ...

    Benzinga
  16. Stocks Turn Mixed, Trade Steady; Facebook Drags On Nasdaq

    IBD
  17. Five Leading International Stocks Below Buy Points

    IBD
  18. Stocks Down 1% In Late Afternoon As Volume Picks Up

    IBD
  19. Charles River Aims To Be 'One-Stop Shop' With Buyout

    IBD
  20. Stocks Reverse This Way And That; Tesla Gains

    IBD
  21. Stocks Off Lows In Afternoon; Facebook Hits New High

    IBD
  22. Stocks Down At Midday On Weak China Export Data

    IBD
  23. Most-Recent Breakouts Among IBD 50 Stocks Mixed So Far

    IBD
  24. Medical Researchers Break Into Top 10 Industry Groups

    IBD
  25. Stocks Holding Gains Midday; Chinese Stocks Rally

    IBD
  26. UPDATE: Morgan Stanley Reiterates on WuXi PharmaTech on Soft 2014 Guidance

    Benzinga
  27. WuXi Beats, Guidance Light

    IBD
  28. WuXi Pharma Q4 Earnings Top, But Q1 Guidance Misses

    IBD
  29. Stocks Mixed In Quiet Session; Gentherm Soars On Earnings

    IBD
  30. Qihoo, WuXi, Akorn Among Last IBD 50 Earnings Reports

    IBD
  31. A Few Chinese Stocks Trading Near Buy Points

    IBD
  32. Nasdaq, S&P 500 Etch Fresh Highs; Akorn, WuXi Extend Gains

    IBD
  33. Stocks Add To Gains; Springleaf Breaks Out

    IBD
  34. Sales Growth Acceleration Expected For WuXi PharmaTech

    IBD
  35. Akorn, WuXi PharmaTech Clear Buy Points, Pace IBD 50

    IBD
  36. Medical Research Providers Ride Higher With Biotechs

    IBD
  37. Stocks Ease From Session Highs; Akorn Breaks Out

    IBD
  38. China Stocks In U.S. Show Little Reaction To Weak Data

    IBD
  39. Akorn, Several Other Leading Stocks Showing Promise

    IBD
  40. IBD 50 Stocks Work On Bases As Market Uptrend Resumes

    IBD
  41. IBD 50 Rises For 2nd-Straight Week; Green Mountain, Kors Soar

    IBD
  42. WuXi Leverages China's Drug Strength As Outsourcer

    IBD
  43. S&P 500, Dow Break Support; Growth Stocks Pressured Again

    IBD
  44. Stocks Off Lows In Afternoon; Ruger Trips Sell Rule

    IBD
  45. Major Averages Slump; Herbalife, American Eagle Take Hits

    IBD
  46. Stocks Tumble On China News; Ctrip.com, Qihoo 360, Wuxi Fall

    IBD
  47. Stocks Mixed As Investors Weigh Earnings; IBM Weighs On Dow

    IBD
  48. Qihoo 360, Sinopec Lead China-Based Gains Tuesday

    IBD
  49. IBD 50's A+ Chinese School Stocks Have Earnings Test

    IBD
  50. Major Indexes On Track For First Gain Of 2014

    IBD
Trading Center